Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3

Core Insights - Surmodics, Inc. announced a presentation discussing updated safety and performance data from the PROWL registry involving 160 patients with symptomatic lower extremity vessels treated with the Pounce™ Thrombectomy Platform [1] Company Overview - Surmodics, Inc. is a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry [1]